What factors are associated with high plasma B-type natriuretic peptide levels in a general Japanese population?

Journal of Human Hypertension

Volumn 19, Issue 2, 2005, Pages 165-172

  Kanda, H ^a   Kita, Y ^a   Okamura, T ^a   Kadowaki, T ^a   Yoshida, Y ^a   Nakamura, Y ^b   Ueshima, H ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b KYOTO WOMEN'S UNIVERSITY   (Japan)

Author keywords

B type natriuretic peptide; General Population; High R wave voltage in the 12 lead ECG; Risk factors; Urinary salt excretion

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CHOLESTEROL; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORRELATION ANALYSIS; ELECTROCARDIOGRAM; FEMALE; GLUCOSE BLOOD LEVEL; HEART FAILURE; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; JAPAN; LEAD BLOOD LEVEL; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; POPULATION RISK; PROTEIN BLOOD LEVEL; R WAVE; RISK FACTOR; SEX DIFFERENCE; SMOKING; SODIUM EXCRETION; SODIUM URINE LEVEL;

ADULT; AGE FACTORS; AGED; BLOOD PRESSURE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; JAPAN; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; RISK FACTORS; SEX FACTORS; SODIUM CHLORIDE, DIETARY;

EID: 13544254592     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001792     Document Type: Article

References (45)

1. Statistics and Information Department. Ministry of Health and Welfare, Labor. Vital Statistics of Japan 2001. Health and Welfare Statistics Association: Tokyo, 2003, pp 390-391.
2. Shimamoto T et al. Trends for coronary heart disease and stroke and their risk factors in Japan. Circulation 1989; 79 503-515.
3. Kiyohara Y, Ueda K, Fujishima M. Smoking and cardiovascular disease in the general population in Japan. J Hypertens 1990; 8 Suppl): S9-S15.
4. Ueshima H. Changes in dietary habits, cardiovascular risk factors and mortality in Japan. Acta Cardiol 1989; 44: 475-477.
5. Ueshima H, Tatara K, Asakura S. Declining mortality from ischemic heart disease and changes in coronary risk factors in Japan, 1956-1980. Am J Epidemiol 1987; 125: 62-72.
6. Okamura T et al. What cause of mortality can we predict by cholesterol screening in the Japanese general population? J Intern Med 2003; 253: 169-180.
7. Itoh A et al. Prognosis of patients with congestive heart failure: its determinants in various heart diseases in Japan. Intern Med 1992; 31: 304-309.
8. Tsuchihashi M et al. Clinical characteristics and prognosis of hospitalized patients with congestive heart failure - a study in Fukuoka, Japan. Jpn Circ J 2000; 64: 953-959.
9. McKee PA et al. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971; 285: 1441-1446.
10. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327: 685-691.
11. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339: 321-328.
12. Wang TJ et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol 2002; 90: 254-258.
13. Nakamura M et al. Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population. Heart 2002; 87: 131-135.
14. Vasan RS et al. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. JAMA 2002; 288: 1252-1259.
15. McDonagh TA et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998; 351: 9-13.
16. Kato J et al. Plasma levels of adrenomedullin and atrial and brain natriuretic peptides in the general population: their relations to age and pulse pressure. Hypertens Res 2002; 25: 887-892.
17. Matsuda M. The significance of plasma BNP measurement in the health check up. Kyorin Igakkai Zasshi 1999; 30: 73-83 (in Japanese).
18. WHO guideline subcommittee. 1999 World Health Organization - International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17: 151-179.
19. Strauer BE. Hypertension and the heart: clinical studies. In: Zanchetti A, Tarazi RC (eds). Handbook of Hypertension, Vol. 7. Elsevier: New York, 1986.
20. He J et al. Dietary sodium intake and incidence of congestive heart failure in overweight US men and women: first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Arch Intern Med 2002; 162: 1619-1624.
21. Myers GL et al. A reference method laboratory network for cholesterol: a model for standardization and improvement of clinical laboratory measurements. Clin Chem 2000; 46: 1762-1772.
22. Nakamura M, Sato S, Shimamoto T. Improvement in Japanese clinical laboratory measurements of total cholesterol and HDL-cholesterol by the US Cholesterol Reference Method Laboratory Network. J Atheroscler Thromb 2003; 10: 145-153.
23. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings: Standards and Procedures for Measurement and Classification. John Wright-PSG Inc.: Litteleton, MA, 1982.
24. Tanaka T et al. A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen. J Hum Hypertens 2002; 16: 97-103.
25. Ghali JK et al. Precipitating factors leading to decompensation of heart failure. Traits among urban blacks. Arch Intern Med 1988; 148: 2013-2016.
26. Jackson FL. An evolutionary perspective on salt, hypertension, and human genetic variability. Hypertension 1991; 17(Suppl 1): 129-132.
27. Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? I: Analysis of observational data among populations. BMJ 1991; 302: 811-815.
28. Midgley JP et al. Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. JAMA 1996; 275: 1590-1597.
29. INTERSALT Co-operative Research Group. The INTERSALT study. J Hum Hypertens 1989; 3: 279-331.
30. Tuomilehto J et al. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet 2001; 357: 848-851.
31. Nagata C et al. Sodium intake and risk of death from stroke in Japanese men and women. Stroke 2004; 35: 1543-1547.
32. Ishimitsu T et al. Responses of natriuretic peptides to acute and chronic salt loading in normotensive and hypertensive subjects. Hypertens Res 1998; 21: 15-22.
33. Kupari M, Koskinen P, Virolainen J. Correlates of left ventricular mass in a population sample aged 36 to 37 years. Focus on lifestyle and salt intake. Circulation 1994; 89: 1041-1050.
34. Beil AH, Schmieder RE. Salt intake as a determinant of cardiac hypertrophy. Blood Press 1995; 2(Suppl): 30-34.
35. Seta H et al. Analysis of factors influencing left ventricular mass and diastolic function in normotensive men. J Cardiol 2001; 37: 249-256 (in Japanese).
36. Mukoyama M et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991; 87: 1402-1412.
37. Yasue H et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90: 195-203.
38. Hirata Y et al. Measurement of plasma brain natriuretic peptide level as a guide for cardiac overload. Cardiovasc Res 2001; 51: 585-591.
39. Tanaka H et al. Epidemiologic studies of stroke in Shibata, a Japanese provincial city: preliminary report on risk factors for cerebral infarction. Stroke 1985; 16: 773-780.
40. Tanaka H et al. Risk factors for cerebral hemorrhage and cerebral infarction in a Japanese rural community. Stroke 1982; 13: 62-73.
41. Lin CH et al. Cerebrovascular diseases in a fixed population of Hiroshima and Nagasaki, with special reference to relationship between type and risk factors. Stroke 1984; 15: 653-660.
42. Ueshima H et al. Multivariate analysis of risk factors for stroke. Eight-year follow-up study of farming villages in Akita, Japan. Prev Med 1980; 9: 722-740.
43. Sekikawa A et al. A "natural experiment" in cardiovascular epidemiology in the early 21st century. Heart 2003; 89: 255-257.
44. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 2003; 107: 223-225.
45. Okonko DO, Anker SD. Anemia in chronic heart failure: pathogenetic mechanisms. J Card Fail 2004; 10(Suppl 1): S5-S9.